Acetohydroxamate, a urease inhibitor, inhibits the covalent binding reaction of complement proteins C3 and C4.
D000818:Animals; D003176:Complement C3 / Q000378:metabolism*; D003181:Complement C4 / Q000378:metabolism*; D006168:Guinea Pigs; D006801:Humans; D006877:Hydroxamic Acids / Q000494:pharmacology*; D008180:Lupus Erythematosus, Systemic / Q000276:immunology; D011485:Protein Binding; D014510:Urease / Q000037:antagonists & inhibitors*
D003176:Complement C3; D003181:Complement C4; D006877:Hydroxamic Acids; C006358:acetohydroxamic acid; D014510:Urease